This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Tyk Medicines (Zhengzhou), Inc., Tyk Medicines Inc.. Active years: 2025.
Company Filing History:
1 out of 1 
1 out of 5 Years Active: 2025
Title: Innovations of Zhongwei Guo in Kinase Inhibitors
Introduction
Zhongwei Guo is a notable inventor based in Henan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work focuses on compounds that have the potential to treat various mutations associated with cancer.
Latest Patents
Zhongwei Guo holds a patent for "Compounds used as kinase inhibitors and application thereof." This patent describes a kinase inhibitor compound of formula I or a pharmaceutically acceptable salt, solvate, or prodrug thereof. The compound exhibits good inhibitory activity on EGFR and Her2 exon 20 insertion mutation, as well as EGFR exon 19 deletion and L858R point mutation of exon 21. He has 1 patent to his name.
Career Highlights
Throughout his career, Zhongwei Guo has worked with various companies, including Tyk Medicines (Zhengzhou), Inc. and Tyk Medicines Inc. His experience in these organizations has allowed him to further his research and development in the pharmaceutical industry.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Zhongwei Guo's innovative work in kinase inhibitors showcases his dedication to advancing medical science. His contributions have the potential to impact cancer treatment significantly.